Results 151 to 160 of about 24,654 (177)
Some of the next articles are maybe not open access.
Journal of Clinical Oncology, 2005
3015 Background: AMN107, a novel aminopyrimidine ATP-competitive inhibitor of Bcr-Abl. AMN107, is 10- to 50-fold more potent than imatinib against Bcr-Abl expressing cell lines, and is effective against most cell lines expressing imatinib-resistant Bcr-Abl mutants.
O. Ottmann +9 more
openaire +1 more source
3015 Background: AMN107, a novel aminopyrimidine ATP-competitive inhibitor of Bcr-Abl. AMN107, is 10- to 50-fold more potent than imatinib against Bcr-Abl expressing cell lines, and is effective against most cell lines expressing imatinib-resistant Bcr-Abl mutants.
O. Ottmann +9 more
openaire +1 more source
Taxodione induces apoptosis in BCR-ABL-positive cells through ROS generation
Biochemical Pharmacology, 2018Chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) are hematopoietic malignancies caused by the constitutive activation of BCR-ABL tyrosine kinase. Although direct BCR-ABL inhibitors, such as imatinib, were initially successful in the treatment of leukemia, many patients developed drug resistance over time due to the gatekeeper ...
Yuki, Uchihara +6 more
openaire +2 more sources
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach
Current Oncology ReportsThe purpose of this review is to summarize the most updated treatment recommendations for pediatric CML, and to discuss current areas of investigation.There is new phase 1 data to support the safety of the non-ATP competitive tyrosine kinase inhibitor (TKI) asciminib in the pediatric cohort.
Jenna M, Menger +3 more
openaire +2 more sources
Advances in BCR/ABL positive ALL
ADVANCES IN CELL AND GENE THERAPY, 2019Netanel A. Horowitz, Jacob M. Rowe
openaire +1 more source
Implicating the bcr/abl Gene in the Pathogenesis of Philadelphia Chromosome-Positive Human Leukemia
1991Publisher Summary The hypothesis that the Philadelphia chromosome might have a causative role in human chronic myelogenous leukemia (CML) was validated by the discovery that the human homologue of the v -abl oncogene of Abelson murine leukemia virus (A-MuLV) mapped to chromosome 9q34, precisely the locus disrupted in the formation of the ...
G Q, Daley, Y, Ben-Neriah
openaire +2 more sources
Leukemia, 2008
The Bcr-Abl fusion gene encodes for the p210(Bcr-Abl) or p185(Bcr-Abl) tyrosine kinase (TK) implicated in the pathogenesis of chronic myelogenous leukemia (CML) or acute lymphoblastic leukemia, respectively. Because Bcr-Abl TK is chaperoned by Hsp90 (90 kDa heat-shock protein), we investigated the effects of novobiocin (NB), an Hsp90 C-terminal ...
L X, Wu +6 more
openaire +1 more source
The Bcr-Abl fusion gene encodes for the p210(Bcr-Abl) or p185(Bcr-Abl) tyrosine kinase (TK) implicated in the pathogenesis of chronic myelogenous leukemia (CML) or acute lymphoblastic leukemia, respectively. Because Bcr-Abl TK is chaperoned by Hsp90 (90 kDa heat-shock protein), we investigated the effects of novobiocin (NB), an Hsp90 C-terminal ...
L X, Wu +6 more
openaire +1 more source
Bcl2 as a therapeutic target in BCR-ABL positive ALL
Klinische Pädiatrie, 2014AK Elder +3 more
openaire +1 more source
Effects of a Selective Inhibitor of the Abl Tyrosine Kinase on the Growth of Bcr–Abl Positive Cells
Nature Medicine, 1996Brian Druker +2 more
exaly

